UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC reduced its position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 4.9% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 1,534,470 shares of the semiconductor company’s stock after selling 78,819 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 1.00% of Synopsys worth $777,040,000 as of its most recent filing with the SEC.
Other hedge funds have also bought and sold shares of the company. Davidson Capital Management Inc. lifted its stake in Synopsys by 33,828.6% in the 3rd quarter. Davidson Capital Management Inc. now owns 4,750 shares of the semiconductor company’s stock valued at $2,405,000 after purchasing an additional 4,736 shares during the last quarter. Swiss National Bank lifted its position in Synopsys by 0.7% during the third quarter. Swiss National Bank now owns 454,800 shares of the semiconductor company’s stock worth $230,306,000 after acquiring an additional 3,200 shares during the last quarter. Harvest Portfolios Group Inc. lifted its position in Synopsys by 3.7% during the third quarter. Harvest Portfolios Group Inc. now owns 42,121 shares of the semiconductor company’s stock worth $21,330,000 after acquiring an additional 1,496 shares during the last quarter. Parnassus Investments LLC acquired a new stake in Synopsys during the third quarter worth approximately $633,469,000. Finally, Jacobs & Co. CA acquired a new stake in Synopsys during the third quarter worth approximately $10,554,000. 85.47% of the stock is currently owned by institutional investors and hedge funds.
Synopsys Trading Down 1.1 %
SNPS opened at $547.74 on Thursday. Synopsys, Inc. has a 1-year low of $457.52 and a 1-year high of $629.38. The company has a market cap of $84.14 billion, a P/E ratio of 56.82, a price-to-earnings-growth ratio of 3.43 and a beta of 1.08. The company has a fifty day moving average price of $524.12 and a two-hundred day moving average price of $545.71.
Wall Street Analyst Weigh In
View Our Latest Research Report on Synopsys
About Synopsys
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Further Reading
- Five stocks we like better than Synopsys
- Stock Dividend Cuts Happen Are You Ready?
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What Does a Stock Split Mean?
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.